Isomorphic Labs Raises $5 Billion Series C to Push AI-Designed Drugs Toward Clinical Trials
Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind in 2021, announced a $5 billion Series C financing round on Nov. 17. The round was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining as a new investor. All existing backers —…